Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.
Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.
You need to be logged in to view this content. Please Log In. Not a Member? Join Us
